Subscribe To
PLSE / Pulse Biosciences (PLSE) Stock: Why The Price Significantly Fell
PLSE News
By Seeking Alpha
August 10, 2023
Pulse Biosciences Inc. (PLSE) Q2 2023 Earnings Call Transcript
Pulse Biosciences Inc. (NASDAQ:PLSE ) Q2 2023 Results Conference Call August 10, 2023 4:30 PM ET Company Participants Philip Taylor - IR Kevin Danahy more_horizontal
By Seeking Alpha
May 11, 2023
Pulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Trip Taylor - Investor Relations more_horizontal
By Seeking Alpha
March 30, 2023
Pulse Biosciences Inc. (PLSE) Q4 2022 Earnings Call Transcript
Pulse Biosciences Inc. (NASDAQ:PLSE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Trip Taylor – Investor Relatio more_horizontal
By Seeking Alpha
August 10, 2022
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2022 Results - Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relat more_horizontal
By Zacks Investment Research
August 10, 2022
Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Lags Revenue Estimates
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers more_horizontal
By Seeking Alpha
May 11, 2022
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2022 Results - Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relation more_horizontal
By Seeking Alpha
March 31, 2022
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2021 Results - Earnings Call Transcript
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Zacks Investment Research
March 31, 2022
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Lags Revenue Estimates
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 22% and 6.22%, respectively, for the quarter ended December 2021. Do the num more_horizontal